Pharmafile Logo

It’s graduation day for Lucid’s inaugural intake of their Futures Academy

September 27, 2018 |  

- PMLiVELucid’s Futures Academy programme has come to an end for its inaugural set of graduates. The programme itself kick-started with an intensive 8-week training course back in October last year – covering everything from the pharmaceutical industry and the regulatory environment to account management, medical writing and brand planning.  The graduates then moved into two different placements for the rest of the year, allowing them to experience one or both sides of the business – medical writing and account handling.

The Futures Academy programme is a true reflection of the human-centric and pioneering spirit of the Lucid Group – individuals and teams working together to  help nurture and build talent.

Angela Young, HR director commented “We strive to harness the talent and ambitions of everyone we work with here are Lucid to create and deliver magic to our clients. This includes graduates joining the organisation. It’s been wonderful to see how the graduates have grown, both personally and professionally, over the last 12 months, and I look forward to watching them continue to flourish on the next steps of their journey with us.”

Emilie Cousin, one of the graduates commented “The Futures Academy gives you all the development opportunities you could wish for. It also allows for as much clever thinking about how to change the health world as you could handle. I’ve already been involved in some really transformative programmes and I’m excited about a future of making a difference to patients by improving health outcomes.”

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD